| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Astria Therapeutics Inc (NASDAQ: ATXS)
ATXS Technical Analysis
5
| As on 9th Jun 2023 ATXS STOCK Price closed @ 11.41 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 6.31 & Strong Buy for SHORT-TERM with Stoploss of 5.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATXSSTOCK Price
| Open | 11.80 | Change | Price | % |
| High | 12.07 | 1 Day | -0.19 | -1.64 |
| Low | 11.31 | 1 Week | 0.47 | 4.30 |
| Close | 11.41 | 1 Month | -0.67 | -5.55 |
| Volume | 97800 | 1 Year | 5.59 | 96.05 |
| 52 Week High 15.79 | 52 Week Low 2.46 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ATXS Daily Charts |
ATXS Intraday Charts |
Whats New @ Bazaartrend |
ATXS Free Analysis |
|
|
ATXS Important Levels Intraday
| RESISTANCE | 12.87 |
| RESISTANCE | 12.40 |
| RESISTANCE | 12.11 |
| RESISTANCE | 11.82 |
| SUPPORT | 11.00 |
| SUPPORT | 10.71 |
| SUPPORT | 10.42 |
| SUPPORT | 9.95 |
ATXS Forecast May 2024
| 4th UP Forecast | 18.06 |
| 3rd UP Forecast | 15.93 |
| 2nd UP Forecast | 14.61 |
| 1st UP Forecast | 13.29 |
| 1st DOWN Forecast | 9.53 |
| 2nd DOWN Forecast | 8.21 |
| 3rd DOWN Forecast | 6.89 |
| 4th DOWN Forecast | 4.76 |
ATXS Weekly Forecast
| 4th UP Forecast | 14.42 |
| 3rd UP Forecast | 13.45 |
| 2nd UP Forecast | 12.86 |
| 1st UP Forecast | 12.26 |
| 1st DOWN Forecast | 10.56 |
| 2nd DOWN Forecast | 9.96 |
| 3rd DOWN Forecast | 9.37 |
| 4th DOWN Forecast | 8.40 |
ATXS Forecast2024
| 4th UP Forecast | 38.23 |
| 3rd UP Forecast | 29.63 |
| 2nd UP Forecast | 24.31 |
| 1st UP Forecast | 19 |
| 1st DOWN Forecast | 3.82 |
| 2nd DOWN Forecast | -1.49 |
| 3rd DOWN Forecast | -6.81 |
| 4th DOWN Forecast | -15.41 |
Astria Therapeutics Inc ( NASDAQ USA Symbol : ATXS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATXS Business Profile
Astria Therapeutics, Inc., a biopharmaceutical company, engages in developing therapies for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-021, a monoclonal antibody inhibitor of plasma kallikrein that is in preclinical development stage for the treatment of hereditary angioedema, a rare genetic disorder causing swelling in the face, limbs, abdomen, and airway. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service